138 related articles for article (PubMed ID: 20610461)
1. Novel strategies in diastolic heart failure.
Paulus WJ
Heart; 2010 Jul; 96(14):1147-53. PubMed ID: 20610461
[No Abstract] [Full Text] [Related]
2. [Diastolic heart failure: are problems in its diagnosis and treatment solvable?].
Tereshchenko SN; Zhirov IV
Ter Arkh; 2009; 81(11):73-6. PubMed ID: 20141020
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic management of heart failure with preserved ejection fraction.
Huang D; Cheng JW
Ann Pharmacother; 2010 Dec; 44(12):1933-45. PubMed ID: 21098754
[TBL] [Abstract][Full Text] [Related]
4. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
[No Abstract] [Full Text] [Related]
5. Diastolic heart failure: state of the science on best treatment practices.
Reddersen LA; Keen C; Nasir L; Berry D
J Am Acad Nurse Pract; 2008 Oct; 20(10):506-14. PubMed ID: 19128346
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
Aronow WS
J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
[TBL] [Abstract][Full Text] [Related]
7. Treating diastolic heart failure.
Voors AA; de Jong RM
Heart; 2008 Aug; 94(8):971-2. PubMed ID: 18625789
[No Abstract] [Full Text] [Related]
8. Treatment of hypertension in heart failure with preserved ejection fraction: role of the kidney.
Shinde AA; Anderson AS
Heart Fail Clin; 2008 Oct; 4(4):479-503. PubMed ID: 18760759
[TBL] [Abstract][Full Text] [Related]
9. Heart failure with normal left ventricular ejection fraction: what is the evidence?
Kindermann M; Reil JC; Pieske B; van Veldhuisen DJ; Böhm M
Trends Cardiovasc Med; 2008 Nov; 18(8):280-92. PubMed ID: 19345315
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic therapies across the continuum of left ventricular dysfunction.
Abraham WT; Greenberg BH; Yancy CW
Am J Cardiol; 2008 Sep; 102(5A):21G-28G. PubMed ID: 18722188
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of a randomized trial to assess the effects of beta-blocker in diastolic heart failure; Japanese Diastolic Heart Failure Study (J-DHF).
Hori M; Kitabatake A; Tsutsui H; Okamoto H; Shirato K; Nagai R; Izumi T; Yokoyama H; Yasumura Y; Ishida Y; Matsuzaki M; Oki T; Sekiya M;
J Card Fail; 2005 Sep; 11(7):542-7. PubMed ID: 16198251
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
13. [The defibrillator is not a comprehensive healing method].
Stiefelhagen P
MMW Fortschr Med; 2006 Aug; 148(31-32):14. PubMed ID: 16938917
[No Abstract] [Full Text] [Related]
14. Strategies to attenuate pathological remodeling in heart failure.
Eapen Z; Rogers JG
Curr Opin Cardiol; 2009 May; 24(3):223-9. PubMed ID: 19318933
[TBL] [Abstract][Full Text] [Related]
15. Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy.
Jneid H; Moukarbel GV; Dawson B; Hajjar RJ; Francis GS
Am J Med; 2007 Dec; 120(12):1090.e1-8. PubMed ID: 18060931
[TBL] [Abstract][Full Text] [Related]
16. Clinical inquiries. Which medications benefit patients with diastolic heart failure?
Crouse M; Flack D; Kerns JW; Martin L; Pham D; Sudireddy R; Knight K
J Fam Pract; 2011 Feb; 60(2):101-2, 108. PubMed ID: 21301643
[No Abstract] [Full Text] [Related]
17. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
Ghanem FA; Movahed A
Rev Cardiovasc Med; 2005; 6(4):206-13. PubMed ID: 16379016
[TBL] [Abstract][Full Text] [Related]
18. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
19. Conclusions on the management of heart failure.
Swedberg K
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5 Suppl 1():S34-6. PubMed ID: 15526241
[TBL] [Abstract][Full Text] [Related]
20. Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.
Tsuyuki RT; Yusuf S; Rouleau JL; Maggioni AP; McKelvie RS; Wiecek EM; Wang Y; Pogue J; Teo KK; White M; Avezum A; Latini R; Held P; Lindgren E; Probstfield J
Can J Cardiol; 1997 Dec; 13(12):1166-74. PubMed ID: 9444298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
